234 results on '"Negri, Donatella"'
Search Results
2. Persistent immunogenicity of integrase defective lentiviral vectors delivering membrane-tethered native-like HIV-1 envelope trimers
3. Integrase Defective Lentiviral Vector Promoter Impacts Transgene Expression in Target Cells and Magnitude of Vector-Induced Immune Responses
4. Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival
5. Enzyme-linked immunospot assay to monitor antigen-specific cellular immune responses in mouse tumor models
6. Therapeutic vaccination with IDLV-SIV-Gag results in durable viremia control in chronically SHIV-infected macaques
7. Immunogenicity, safety, and efficacy of sequential immunizations with an SIV-based IDLV expressing CH505 Envs
8. Different configurations of SARS-CoV-2 spike protein delivered by integrase-defective lentiviral vectors induce persistent functional immune responses, characterized by distinct immunogenicity profiles
9. New Monoclonal Antibodies Specific for Different Epitopes of the Spike Protein of SARS-CoV-2 and Its Major Variants: Additional Tools for a More Specific COVID-19 Diagnosis
10. IDLV-HIV-1 Env vaccination in non-human primates induces affinity maturation of antigen-specific memory B cells
11. Safety and efficiency modifications of SIV-based integrase-defective lentiviral vectors for immunization
12. Isolation and Characterization of Mouse Monoclonal Antibodies That Neutralize SARS-CoV-2 and Its Variants of Concern Alpha, Beta, Gamma and Delta by Binding Conformational Epitopes of Glycosylated RBD With High Potency
13. Persistent Immunogenicity of Integrase Defective Lentiviral Vectors delivering membrane tethered Native-Like HIV-1 Envelope Trimers
14. Seasonal betacoronavirus antibodies expansion post BNT161b2 vaccination associates with reduced SARS-CoV-2 VoCs neutralization
15. Renal epithelial cells produce and spread HIV-1 via T-cell contact
16. Anticancer Effects of Sublingual Type I IFN in Combination with Chemotherapy in Implantable and Spontaneous Tumor Models
17. Integrase-Defective Lentiviral Vector Is an Efficient Vaccine Platform for Cancer Immunotherapy
18. COVID-BioB Cohort Study: the neutralizing antibody response to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for virus control and survival
19. Robust Neutralizing Antibodies to SARS-CoV-2 Develop and Persist in Subjects with Diabetes and COVID-19 Pneumonia
20. Integrase-Defective Lentiviral Vectors for Delivery of Monoclonal Antibodies against Influenza
21. Successful therapeutic vaccination with integrase defective lentiviral vector expressing nononcogenic human papillomavirus E7 protein
22. Integrase Defective, Nonintegrating Lentiviral Vectors
23. Development and Preclinical Evaluation of an Integrase Defective Lentiviral Vector Vaccine Expressing the HIVACAT T Cell Immunogen in Mice
24. Skeletal Muscle Is an Antigen Reservoir in Integrase-Defective Lentiviral Vector-Induced Long-Term Immunity
25. Polyclonal Treg cells enhance the activity of a mucosal adjuvant
26. Toward Integrase Defective Lentiviral Vectors for Genetic Immunization
27. Efficiency of T cell triggering by anti-CD3 monoclonal antibodies (mAb) with potential usefulness in bispecific mAb generation
28. Comparison of three different methods for radiolabelling human activated T lymphocytes
29. Macaca mulatta, fascicularis and nemestrina in AIDS vaccine development
30. PROTECTION AGAINST AIDS IN TAT-PROTEIN VACCIN- ATED MONKEYS AFTER RECHALLENGE WITH A HIGH DOSE OF SHIV89·6PCY243 IN THE ABSENCE OF DETECT- ABLE ANTI-ENV AND ANTI-GAG ANTIBODIES AND ANTI- GAG CELLULAR RESPONSES: ABSTRACT #121
31. LONG-TERM EFFICACY OF A CANDIDATE T-CELL HIV/ AIDS MULTIPROTEIN VACCINE FOLLOWING MUCOSAL CHALLENGE WITH SIVMAC251 IN CYNOMOLGUS MON- KEYS: ABSTRACT #117
32. Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeys
33. T-cell-mediated protective efficacy of a systemic vaccine approach in cynomolgus monkeys after SIV mucosal challenge
34. Effect of vaccination with recombinant modified vaccinia virus Ankara expressing structural and regulatory genes of SIVmacJ5 on the kinetics of SIV replication in cynomolgus monkeys
35. SHIV89.6P pathogenicity in cynomolgus monkeys and control of viral replication and disease onset by human immunodeficiency virus type 1 Tat vaccine
36. Approaches to implement bispecific antibody treatment of ovarian carcinoma
37. Simian immunodeficiency virus-Vpx for improving integrase defective lentiviral vector-based vaccines
38. Persistence of Integrase-Deficient Lentiviral Vectors Correlates with the Induction of STING-Independent CD8+ T Cell Responses
39. Integrase defective lentiviral vector as a vaccine platform for delivering Influenza antigens
40. ROLE OF CYTOKINES IN CANCER CACHEXIA IN A MURINE MODEL OF INTRACEREBRAL INJECTION OF HUMAN TUMOURS
41. Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P)
42. Integrase Defective Lentiviral Vector as a Vaccine Platform for Delivering Influenza Antigens
43. Intranasal Administration of Integrase Defective Lentiviral Vectors Expressing mAbs Protects from H5 Influenza Virus Challenge In Vivo
44. Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus Macaques
45. Murine Granulocyte–Macrophage Colony-Stimulating Factor Expressed from a Bicistronic Simian Immunodeficiency Virus-Based Integrase-Defective Lentiviral Vector Does Not Enhance T-Cell Responses in Mice
46. Evaluation of HIV-1 integrase inhibitors on human primary macrophages using a luciferase-based single-cycle phenotypic assay
47. Optimization of Mucosal Responses after Intramuscular Immunization with Integrase Defective Lentiviral Vector
48. Mucosal Immunization with Integrase-Defective Lentiviral Vectors Protects against Influenza Virus Challenge in Mice
49. Successful therapeutic vaccination with integrase defective lentiviral vector expressing nononcogenic human papillomavirus E7 protein
50. Immunization with an SIV-based IDLV Expressing HIV-1 Env1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus Macaques
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.